UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma

Leukemia & lymphoma, 2021-01, Vol.62 (1), p.58-67

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma

Leukemia & lymphoma, 2018-04, Vol.59 (4), p.863-870

2018

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL

Leukemia & lymphoma, 2020-05, Vol.61 (6), p.1380-1387

2020

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment SUV max may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL

Leukemia & lymphoma, 2020-06, Vol.61 (6), p.1380-1387

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma

Leukemia & lymphoma, 2013-12, Vol.54 (12), p.2631-2638

2013

Link zum Volltext

Verfügbarkeit prüfen

Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma

Leukemia & lymphoma, 2017-12, Vol.58 (12), p.2833-2844

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas

Leukemia & lymphoma, 2012-01, Vol.53 (1), p.50-56

2012

Link zum Volltext

Verfügbarkeit prüfen

Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study

Leukemia & lymphoma, 2012-05, Vol.53 (5), p.801-806

2012

Link zum Volltext

Verfügbarkeit prüfen

Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma

Leukemia & lymphoma, 2006-03, Vol.47 (3), p.481-485

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma

Leukemia & lymphoma, 2006-09, Vol.47 (9), p.1818-1821

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical Implications of PET-Negative Residual CT Masses after Chemotherapy for Diffuse Large B-Cell Lymphoma

Leukemia & lymphoma, 2013-05, Vol.54 (12)

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of serum CD44, ICAM-1 and VCAM-1 levels in patients with indolent non-Hodgkin lymphomas

Leukemia & lymphoma, 2011-10, Vol.53 (1), p.50-56

2011

Link zum Volltext

Verfügbarkeit prüfen

The Role of Ifosfamide in the Treatment of Lymphomas

Leukemia & lymphoma, 1999-08, Vol.34 (5-6), p.433-441

Hagemeister, Fredrick B.

1999

Link zum Volltext

Verfügbarkeit prüfen

Hodgkin's Disease: The Next Decade

Leukemia & lymphoma, 1996, Vol.21 (1-2), p.53-61

Hagemeister, Fredrick B.

1996

Link zum Volltext

Verfügbarkeit prüfen

Are Alkylating Agents a Necessary Component in the Therapy of Hodgkin's Disease

Leukemia & lymphoma, 1993, Vol.10 (S1), p.91-97

Hagemeister, Fredrick B.

1993

Link zum Volltext

Verfügbarkeit prüfen

Results of Treatment of Small Non-Cleaved Cell Lymphoma in Patients Without Positive HIV Serology

Leukemia & lymphoma, 1993, Vol.10 (S1), p.21-27

Hagemeister, Fredrick B.

1993

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Fludarabine and Paclitaxel for the Treatment of Low-Grade Non-Hodgkin's Lymphoma

Leukemia & lymphoma, 1997, Vol.26 (1-2), p.77-82

1997

Link zum Volltext

Verfügbarkeit prüfen

Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase

Leukemia & lymphoma, 1995, Vol.18 (1-2), p.87-92

1995

Link zum Volltext

Verfügbarkeit prüfen

A New Chemotherapy Regimen for Treatment of Hodgkin's Disease Associated with Minimal Genotoxicity

Leukemia & lymphoma, 1993, Vol.9 (6), p.503-508

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieLeukemia & Lymphoma

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Hematology
(14)
Life Sciences & Biomedicine
(14)
Oncology
(14)
Science & Technology
(14)
Adult
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Middle Aged
(10)
Aged
(9)
Male
(8)
Female
(7)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(6)
Treatment Outcome
(6)
Prognosis
(5)
Follow-Up Studies
(4)
Lymphoma, Non-Hodgkin - Drug Therapy
(4)
Neoplasm Staging
(4)
Survival Rate
(4)
Aged, 80 And Over
(3)
Chemotherapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Taylor & Francis:Master (3349 titles)
(19)
Taylor & Francis Current Content Access
(19)
MEDLINE
(15)

Zeitschrift / Serie

Leuk Lymphoma
(1)

Menü

Weitere Dienste

Einstellungen

Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma

Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma

Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL

Pretreatment SUV max may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL

Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma

Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma

Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas

Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study

Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma

Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma

Clinical Implications of PET-Negative Residual CT Masses after Chemotherapy for Diffuse Large B-Cell Lymphoma

Prognostic value of serum CD44, ICAM-1 and VCAM-1 levels in patients with indolent non-Hodgkin lymphomas

The Role of Ifosfamide in the Treatment of Lymphomas

Hodgkin's Disease: The Next Decade

Are Alkylating Agents a Necessary Component in the Therapy of Hodgkin's Disease

Results of Treatment of Small Non-Cleaved Cell Lymphoma in Patients Without Positive HIV Serology

Phase I Study of Fludarabine and Paclitaxel for the Treatment of Low-Grade Non-Hodgkin's Lymphoma

Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase

A New Chemotherapy Regimen for Treatment of Hodgkin's Disease Associated with Minimal Genotoxicity

Aktive Filter

Suchergebnisse filtern